Source: Annual Congress 2004 - Community acquired and nosocomial pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. B. Koroleva, A. M. Borodin, S. V. Hvatova (Alexander M Borodin, Russia). Detection parachlamydia acanthamoeba and simkania negevensis in young patients with community-acquired pneumonia (CAP). Eur Respir J 2004; 24: Suppl. 48, 2545

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Viral and mixed virus-bacteria community-acquired pneumonia (CAP) in hospitalized adults Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Simkania negevensis and community-acquired pneumonia: a pediatric survey Source: Eur Respir J 2006; 28: Suppl. 50, 310s Year: 2006 Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized? Source: Annual Congress 2009 - Pulmonary infections Year: 2009 Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Detection of liver function in patients with severe community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Role of virus in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Bacterial infections and community-acquired pneumonia in children Source: Annual Congress 2011 - Paediatric Year in Review Year: 2011 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 The peculiarity of community-acquired pneumonia (CAP) express-diagnostic by means of bacterioscopy Source: Eur Respir J 2004; 24: Suppl. 48, 413s Year: 2004 Bacterial community-acquired pneumonia Source: Eur Respir Monogr 2014; 66: 98-111 Year: 2014 MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Source: Eur Respir J 2009; 34: 1470-1476 Year: 2009 Clostridium difficile infection following community-acquired pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011